Key facts
- PLLA (Sculptra)
- Poly-L-lactic acid microparticles mixed with water; no volume from the product on the day, collagen builds over months
- PCL (Ellansé)
- Polycaprolactone microspheres of about 25 to 50 µm in a gel carrier; gel gives volume on the day, collagen follows
- CaHA (Radiesse)
- Calcium hydroxylapatite microspheres of 25 to 45 µm in a gel carrier; fills on the day, stimulates afterwards, and can be hyperdiluted for skin quality
- Reversibility
- None by hyaluronidase, which acts on hyaluronic acid only
- Suits
- Diffuse structural volume loss of the mid-face, temples and jawline; not lips, tear troughs or the glabella
What is a collagen biostimulator?
A collagen biostimulator is an injectable whose main effect comes from the tissue's response to it rather than from the material itself. After injection, microparticles sit in the deep dermis or subdermal plane as a lattice. Fibroblasts treat that lattice as a work order: over the following months they lay down new type I collagen around it while the particles slowly biodegrade. What remains is the patient's own collagen, not resident product.
The three common materials behave differently on the day. Sculptra is poly-L-lactic acid supplied as microparticles mixed with water, so the immediate fullness is mostly water and swelling that settle within days; the change comes later. Ellansé is polycaprolactone microspheres in a carboxymethylcellulose gel, and Radiesse is calcium hydroxylapatite microspheres in a similar carrier; in both, the gel gives volume at once and collagen forms around the microspheres as the gel is absorbed. The microspheres are metabolised over many months.
How is it used in aesthetic medicine?
This mechanism suits diffuse, structural volume loss: the deflation of the mid-face, temples and jawline that arrives with age or after significant weight loss, where the aim is support rebuilt gradually rather than a line spot-filled. Ellansé's firmer scaffold suits structural definition along the jawline and chin; on the nose bridge Dr Sin Yong usually works with calcium hydroxylapatite or polycaprolactone because a firmer product holds projection more predictably, with hyaluronic acid where a dissolvable option is preferred.
Radiesse has a second use the others lack. Hyperdiluted with saline and lidocaine and spread in a thin superficial layer, it stops being a volumiser and becomes a skin-quality treatment for the neck, décolleté, arms, abdomen and hands, planned as a different procedure from the undiluted form. Because an overcorrection cannot be dissolved, the working rule is conservative dosing, correct depth and staged placement: under-treat, wait, reassess. Collagen keeps building after the patient leaves.
“A biostimulator cannot be dissolved. That single fact should shape every decision about using one.”
Dr Sin YongOn why reversibility decides how biostimulators are planned
What is it often confused with?
A hyaluronic acid filler is volume you can see the day it goes in and dissolve with hyaluronidase if it disappoints. A biostimulator is neither of those things. Hyaluronidase does nothing to PLLA, PCL or CaHA, so a clinic offering to dissolve Sculptra or Ellansé is describing something that does not happen; nodules and unevenness after these products are managed case by case, with ultrasound to see what is there and how deep it sits.
Biostimulators are also confused with skin boosters, because PDLLA and hyperdiluted CaHA are sometimes grouped with them. A skin booster acts superficially on hydration and texture; a biostimulator used undiluted is placed deep and aimed at structure. And although PLLA and PCL also appear in thread lifts, a thread is a suture with a direction, not a suspension of particles. The overview of the class is on the collagen biostimulators page, with separate pages for Sculptra, Ellansé and Radiesse.
When is it not the answer?
Lips, tear troughs and the glabella are areas that punish non-dissolvable product, and biostimulators are generally kept out of them; where filler is appropriate there, hyaluronic acid is chosen because it can be reversed. Sharp lines are not a biostimulator problem either, because the change is diffuse and gradual. Someone who wants an immediate, adjustable result is better served by hyaluronic acid.
A biostimulator should not be placed over unmapped previous filler, and lumps or heaviness after earlier injections usually call for subtraction rather than more product. Papules and nodules are a recognised risk, reported in 17.2 per cent of Sculptra patients in the US pivotal trial and mostly resolving over time. Existing nodules from PLLA or PCL placed elsewhere are assessed under filler correction, with imaging first, and never with a promise to dissolve them.
